IL-33 in Chronic Respiratory Disease: From Preclinical to Clinical Studies

被引:35
作者
Donovan, Chantal [1 ,2 ,3 ,4 ]
Hansbro, Philip M. [1 ,2 ,3 ]
机构
[1] Centenary Inst, Ctr Inflammat, Sydney, NSW 2050, Australia
[2] Univ Technol Sydney, Fac Sci, Sydney, NSW 2050, Australia
[3] Univ Newcastle, Prior Res Ctr Hlth Lungs, Hunter Med Res Inst, Newcastle, NSW 2308, Australia
[4] Royal Prince Alfred Hosp Grounds, Centenary Inst, Ctr Inflammat, Bldg 93,John Hopkins Dr, Camperdown, NSW 2050, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
IL-33; anti-IL-33; ST2; eosinophils; asthma; COPD; THYMIC STROMAL LYMPHOPOIETIN; VIRUS-INDUCED ASTHMA; TYPE-2; INFLAMMATION; AIRWAY INFLAMMATION; PROGENITOR CELLS; CYTOKINE; LUNG; INTERLEUKIN-33; EXACERBATIONS; PREDISPOSES;
D O I
10.1021/acsptsci.9b00099
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
IL-33 has been deorphanized as a member of the IL-1 family and has key roles as an alarmin and cytokine with potent capacity to drive type 2 inflammation. This has led to a plethora of studies surrounding its role in chronic diseases with a type 2 inflammatory component. Here, we review the roles of IL-33 in two chronic respiratory diseases, asthma and chronic obstructive pulmonary disease (COPD). We discuss the hallmark and paradigm-shifting studies that have contributed to our understanding of IL-33 biology. We cover animal studies that have elucidated the mechanisms of IL-33 and assessed the role of anti-IL-33 treatment and immunization against IL-33. We highlight key clinical evidence for the potential of targeting increased IL-33 in respiratory diseases including exacerbations, and we outline current clinical trials using an anti-IL-33 monoclonal antibody in asthma patients. Finally, we discuss some of the challenges that have arisen in IL-33 biology and highlight potential future directions in targeting this cytokine in chronic respiratory diseases.
引用
收藏
页码:56 / 62
页数:7
相关论文
共 55 条
[1]   Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme [J].
Afonina, Inna S. ;
Muller, Christina ;
Martin, Seamus J. ;
Beyaert, Rudi .
IMMUNITY, 2015, 42 (06) :991-1004
[2]   Oxidative stress enhances the expression of IL-33 in human airway epithelial cells [J].
Aizawa, Hiroyuki ;
Koarai, Akira ;
Shishikura, Yutaka ;
Yanagisawa, Satoru ;
Yamaya, Mutsuo ;
Sugiura, Hisatoshi ;
Numakura, Tadahisa ;
Yamada, Mitsuhiro ;
Ichikawa, Tomohiro ;
Fujino, Naoya ;
Noda, Masafumi ;
Okada, Yoshinori ;
Ichinose, Masakazu .
RESPIRATORY RESEARCH, 2018, 19
[3]   Airway epithelium-shifted mast cell infiltration regulates asthmatic inflammation via IL-33 signaling [J].
Altman, Matthew C. ;
Lai, Ying ;
Nolin, James D. ;
Long, Sydney ;
Chen, Chien-Chang ;
Piliponsky, Adrian M. ;
Altemeier, William A. ;
Larmore, Megan ;
Frevert, Charles W. ;
Mulligan, Michael S. ;
Ziegler, Steven F. ;
Debley, Jason S. ;
Peters, Michael C. ;
Hallstrand, Teal S. .
JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (11) :4979-4991
[4]   Combined blockade of IL-25, IL-33 and TSLP mediates amplified inhibition of airway inflammation and remodelling in a murine model of asthma [J].
An, Gao ;
Wang, Wenjun ;
Zhang, Xin ;
Huang, Qiong ;
Li, Qin ;
Chen, Shihao ;
Du, Xiaonan ;
Corrigan, Chris J. ;
Huang, Kewu ;
Wang, Wei ;
Chen, Yan ;
Ying, Sun .
RESPIROLOGY, 2020, 25 (06) :603-612
[5]   Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease [J].
Byers, Derek E. ;
Alexander-Brett, Jennifer ;
Patel, Anand C. ;
Agapov, Eugene ;
Dang-Vu, Geoffrey ;
Jin, Xiaohua ;
Wu, Kangyun ;
You, Yingjian ;
Alevy, Yael ;
Girard, Jean-Philippe ;
Stappenbeck, Thaddeus S. ;
Patterson, G. Alexander ;
Pierce, Richard A. ;
Brody, Steven L. ;
Holtzman, Michael J. .
JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (09) :3967-3982
[6]   The relationship between inflammation and remodeling in childhood asthma: A systematic review [J].
Castro-Rodriguez, Jose A. ;
Saglani, Sejal ;
Rodriguez-Martinez, Carlos E. ;
Oyarzun, Maria A. ;
Fleming, Louis ;
Bush, Andrew .
PEDIATRIC PULMONOLOGY, 2018, 53 (06) :824-835
[7]   Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family [J].
Cayrol, Corinne ;
Girard, Jean-Philippe .
IMMUNOLOGICAL REVIEWS, 2018, 281 (01) :154-168
[8]   Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis [J].
Chen, Yi-Ling ;
Gutowska-Owsiak, Danuta ;
Hardman, Clare S. ;
Westmoreland, Melanie ;
MacKenzie, Teena ;
Cifuentes, Liliana ;
Waithe, Dominic ;
Lloyd-Lavery, Antonia ;
Marquette, Allison ;
Londei, Marco ;
Ogg, Graham .
SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (515)
[9]   Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33 [J].
Christianson, Christina A. ;
Goplen, Nicholas P. ;
Zafar, Iram ;
Irvin, Chaoyu ;
Good, James T., Jr. ;
Rollins, Donald R. ;
Gorentla, Balachandra ;
Liu, Weimin ;
Gorska, Magdalena M. ;
Chu, HongWei ;
Martin, Richard J. ;
Alam, Rafeul .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 136 (01) :59-U142
[10]   Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation [J].
Cohen, E. Suzanne u ;
Scott, Ian C. ;
Majithiya, Jayesh B. ;
Rapley, Laura ;
Kemp, Benjamin P. ;
England, Elizabeth ;
Rees, D. Gareth ;
Overed-Sayer, Catherine L. ;
Woods, Joanne ;
Bond, Nicholas J. ;
Veyssier, Christel Seguy ;
Embrey, Kevin J. ;
Sims, Dorothy A. ;
Snaith, Michael R. ;
Vousden, Katherine A. ;
Strain, Martin D. ;
Chan, Denice T. Y. ;
Carmen, Sara ;
Huntington, Catherine E. ;
Flavell, Liz ;
Xu, Jianqing ;
Popovic, Bojana ;
Brightling, Christopher E. ;
Vaughan, Tristan J. ;
Butler, Robin ;
Lowe, David C. ;
Higazi, Daniel R. ;
Corkill, Dominic J. ;
May, Richard D. ;
Sleeman, Matthew A. ;
Mustelin, Tomas .
NATURE COMMUNICATIONS, 2015, 6